Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Neoadjuvant Chemotherapy in Resectable NSCLC Stages IB, IIA, IIB, and IIIA/T3 But Not IIIA/N2

Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).

Randomisation between 3 courses of neoadjuvant Carboplatin plus Paclitaxel or no chemotherapy before surgery.

Inclusion Criteria:

• NSCLC
• Stages IB, IIA, IIB, IIIA/T3
• Lung function test allowing surgery
• Age 18-75 years

Exclusion Criteria:

• Poor lung function
• Performance status 3-4
• Mediastinal lymph node involvement